Health M&A could increase in 2013, analysts say

10/26/2012 | Bloomberg

Health companies have large cash reserves, and drugmakers are shifting their focus from cost-cutting to filling pipelines through mergers and acquisitions, industry analysts say. Next year could top the 2,076 health deals worth $166 billion announced in the past 12 months. "What tends to drive that is the need. There's clearly a need for larger companies who are facing patent cliffs and whose own R&D machines have not panned out, to find growth," he said.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC